All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Glp1 Medication Comparison Tool: Semaglutide vs Tirzepatide

This glp1 medication comparison tool sets semaglutide and tirzepatide side by side on mechanism, weight loss results, and side effects to prepare your visit.

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Should you ask your provider about semaglutide or tirzepatide? A GLP-1 medication comparison tool puts the key differences side by side so you can walk into your consultation informed and ready with the right questions. Both medications work. Both have strong clinical evidence.

Should you ask your provider about semaglutide or tirzepatide? A GLP-1 medication comparison tool puts the key differences side by side so you can walk into your consultation informed and ready with the right questions. Both medications work. Both have strong clinical evidence. But they're not identical.

Key Takeaways: - Learn how semaglutide and tirzepatide work differently - Side-by-Side Comparison Chart - Comparing Side Effects - Factors to Discuss With Your Provider - Learn how to use this comparison to prepare for your appointment

This guide compares the two most popular GLP-1 medications across every factor that matters (mechanism, dosing, results, side effects, and cost.

How Semaglutide and Tirzepatide Work Differently

Both medications belong to the GLP-1 class, but their mechanisms have a key difference.

Semaglutide is a GLP-1 receptor agonist. It mimics the natural GLP-1 hormone your body produces after eating. This hormone signals your brain to feel full, slows stomach emptying, and helps regulate blood sugar. Semaglutide activates one receptor.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It activates two receptors) both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). GIP is another incretin hormone that plays a role in fat metabolism, insulin secretion, and appetite regulation. This dual action may explain why tirzepatide showed slightly greater weight loss in clinical trials.

Think of it this way: semaglutide turns one dial. Tirzepatide turns two.

Both are administered as once-weekly subcutaneous injections. Both follow a gradual titration schedule where you start at a low dose and increase over time.

For a deeper look at each medication individually, check out our and .

"The key to successful GLP-1 therapy is setting realistic expectations and supporting patients through the titration phase. The side effects are manageable for most people, but they need to know what to expect.", Dr. Caroline Apovian, MD, Harvard Medical School

Side-by-Side Comparison Chart

Here's how the two medications stack up across key factors:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Glp1 Medication Comparison Tool: doctor and nurse talking in a brightly lit medical office
Factor Semaglutide Tirzepatide
Mechanism GLP-1 agonist Dual GIP/GLP-1 agonist
Frequency Once weekly Once weekly
Starting dose 0.25 mg 2.5 mg
Maximum dose 2.4 mg 15 mg
Titration period ~16-20 weeks ~20-24 weeks
Avg. Weight loss ~15% body weight ~15-22% body weight
Common side effects Nausea, vomiting, diarrhea, constipation Nausea, vomiting, diarrhea, constipation
Injection route Subcutaneous Subcutaneous

Free Download: Universal Peptide Dose Conversion Table Print this reference alongside your GLP-1 comparison chart. Covers dose conversions for semaglutide, tirzepatide, and common peptides. Get yours free (we'll email it to you instantly.

[Download CTA Button]


Important note: The weight loss percentages come from separate clinical trials with different study populations. Direct head-to-head comparison data is limited. Your individual response to each medication may differ from the averages.

Comparing Side Effects

The side effect profiles are similar but not identical. Both medications share the most common side effects because they both activate GLP-1 receptors.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Shared side effects (most common): - Nausea (especially during dose increases) - Vomiting - Diarrhea - Constipation - Decreased appetite (this is also the therapeutic effect) - Injection site reactions

Frequency comparison: In clinical trials, gastrointestinal side effects occurred in roughly 40-50% of participants for both medications. But the majority were mild to moderate and decreased over time. Most side effects peak during dose escalation and improve once your body adjusts.

How to manage side effects: Our covers practical strategies for handling nausea, constipation, and other common issues. Small meals, adequate hydration, and eating slowly can make a significant difference.

If you're experiencing side effects that don't improve, your provider may recommend slowing your titration schedule, adjusting your dose, or switching medications. This is one advantage of working with a platform like ) your provider can adjust your treatment plan based on your response.

Factors to Discuss With Your Provider

The "best" GLP-1 medication depends on your individual situation. Here are factors worth discussing during your consultation.

Your health history. Certain conditions may make one medication more appropriate than the other. For example, if you have type 2 diabetes, both medications are effective for blood sugar management, but your provider may have a preference based on your specific metabolic profile.

Your weight loss goals. If you have a significant amount of weight to lose, the potentially greater average weight loss with tirzepatide may factor into the decision. But remember (individual responses vary widely.

Your tolerance for side effects. If you're concerned about gastrointestinal side effects, your provider may start with the medication that has the slower titration to minimize initial discomfort.

Cost and access. Compounded versions of both medications are available through at transparent pricing. Check our for current rates.

Previous experience. If you've tried one medication and didn't respond well, switching to the other is a reasonable conversation to have with your provider.

You can use our to get started with a provider evaluation. The quiz collects your health information so your provider can make an informed recommendation.

How to Use This Comparison to Prepare for Your Appointment

Don't just show up and ask "which one is better?" Instead, use this comparison to ask targeted questions.

Ask: "Based on my health history, which mechanism) single or dual receptor (do you think would be more beneficial for me?"

Ask: "Given my weight loss goals, what's a realistic timeline with each medication?"

Ask: "What's your approach if I experience side effects that don't resolve during titration?"

Ask: "If I start with one and it doesn't work well, can we switch to the other?"

Coming prepared with specific questions shows your provider that you've done your homework. It also leads to more productive appointments.

The lets you track your progress on whichever medication your provider recommends. You can log doses, weight, side effects, and other metrics to share during follow-up appointments.

Switching between semaglutide and tirzepatide: what to expect

Yes, switching is possible under provider guidance. Your provider will determine the appropriate starting dose of the new medication and create a new titration schedule. There's typically no washout period needed) you can transition directly. Discuss the timing and approach with your provider.

Is tirzepatide always better than semaglutide for weight loss?

Not necessarily. Clinical trial averages favor tirzepatide at higher doses, but individual responses vary. Some people respond better to semaglutide. The best medication for you depends on your unique biology, health conditions, and tolerance. Your provider helps determine the right choice.

Do semaglutide and tirzepatide need a prescription?

Yes. Both semaglutide and tirzepatide are prescription medications that require evaluation by a licensed healthcare provider. FormBlends connects you with providers who can evaluate your eligibility and prescribe the appropriate medication based on your health profile.

Can I take both medications at the same time?

No. Semaglutide and tirzepatide shouldn't be taken simultaneously. They activate overlapping receptors, and combining them would increase the risk of side effects without established safety data. Your provider will prescribe one or the other.

Which of these two GLP-1 medications suits your goals?

The research is clear. The options are available. The only question is whether it's right for you. A FormBlends provider can help you decide (no pressure, no commitment.


  1. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  2. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  3. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
  2. Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  4. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  5. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  6. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  7. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563

This article is for educational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider before starting, changing, or stopping any medication or supplement. FormBlends connects you with licensed providers who can evaluate your individual health needs.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Glp1 Medication Comparison Tool: Semaglutide vs Tirzepatide
FormBlends guide cover for Glp1 Medication Comparison Tool: Semaglutide vs Tirzepatide.

Research Snapshot

Head-to-head comparison
Page type
Head-to-head comparison
Page metadata
Page updated
2026-04-01
Page metadata
FormBlends official source
Official source
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

Comparison decision path

Use this comparison to narrow the provider review question

Related treatment context

Glp1 Medication Comparison Tool: Semaglutide vs Tirzepatide should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

Compare available products and select the relevant treatment page for its specific next step.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

Patient Experience

GLP-1 Medication Comparison Chart 2026

GLP-1 Medication Comparison Chart 2026: patient experience guidance on comparisons and alternatives, with safety context, decision points, and...

GLP-1 Weight Loss

GLP-1 Medication Comparison Chart

Choosing a GLP-1 medication can feel overwhelming. There are multiple options on the market, each with different dosing schedules, efficacy profiles, side effects, and costs.

Provider Comparisons

GLP-1 Medication Shortage Alternatives

You've been prescribed a GLP-1 medication, but your pharmacy says it's out of stock. This GLP-1 medication shortage alternatives resource covers the essential information you need to make informed decisions.

Peptide Therapy

Compounded GLP-1 Medication Safety Standards

When you inject a compounded GLP-1 medication, you're trusting that it was made safely. That trust should be earned, not assumed.

Lifestyle & Wellness

Tracking Body Composition Changes On GLP-1 Medication

Weight loss is not just about the number on the scale. This body composition changes GLP-1 resource covers the essential information you need to make informed decisions.

Peptide Therapy

GLP-1 Medication Recalls How To Stay Informed

Knowing how to respond to a GLP-1 medication recall can protect your health and prevent you from using an unsafe product. Recalls are uncommon, but they do happen for both brand-name and compounded medications.

GLP-1 Weight Loss

Am I Eligible For GLP-1 Medication Complete Bmi Health Criteria Guide

You have probably heard about GLP-1 medications and the results people are seeing. Maybe a friend lost 40 pounds, or you saw a story online that caught your attention.

Peptide Therapy

How To Spot Fake GLP-1 Medication Online

The demand for GLP-1 medications has created a booming market for fake GLP-1 medication online.

GLP-1 Weight Loss

Comparing All GLP-1 Medications

Looking for a GLP-1 medication comparison chart that puts every option side by side? You are in the right place.

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.